It’s . Today, right at this moment, we’re hard at work for patients like Vanessa who have a critical therapeutic need. We approach everything we do with a sense of urgency because, for them, we understand the clock is ticking—and that every second makes a difference.
Kiniksa received FDA approval for Arcalyst on March 18, 2021
Serving those who
don’t have time to wait.
Living with a debilitating disease brings questions that go far beyond the symptoms—there’s the fear and frustration of not knowing when, or if, there will ever be an answer. That’s why we’re relentless about making every moment matter at Kiniksa: because every second brings us closer to creating a better future for patients. Hear stories from the people who live with the uncertainty of these diseases every day.
Connect with us on social media for up-to-date news and discoveries.